Eurofins-Cerep Revenue and Competitors

CELLE L'EVESCAULT, France

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Eurofins-Cerep's estimated annual revenue is currently $34M per year.(i)
  • Eurofins-Cerep's estimated revenue per employee is $201,000

Employee Data

  • Eurofins-Cerep has 169 Employees.(i)
  • Eurofins-Cerep grew their employee count by 33% last year.

Eurofins-Cerep's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$45.6M2270%N/AN/A
#2
$19.3M965%N/AN/A
#3
$36.2M1805%N/AN/A
#4
$34M16933%N/AN/A
#5
$173.7M86420%N/AN/A
#6
$45M2242%N/AN/A
#7
$48.2M2406%N/AN/A
#8
$22.1M1108%N/AN/A
#9
$22.1M110-13%N/AN/A
#10
$27.5M1371%N/AN/A
Add Company

What Is Eurofins-Cerep?

Eurofins Scientific is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries. The Group believes it is the world leader in food, environment and pharmaceutical products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, advanced material sciences and for supporting clinical studies. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. Group's key figures (as of March 2019) are approx. 3.8 billion Euros turnover, over 800 laboratories across 47 countries and about 45,000 staff. Eurofins Cerep : 30 ans au service de la recherche pharmacologique : Anticiper les effets cliniques des médicaments Leader mondial des sociétés de recherche sous contrat pour le criblage et le profilage in vitro de candidats-médicaments. Spécialiste de la pharmacologie in vitro , Eurofins-Cerep (au sein de la division Eurofins Discovery du Groupe Eurofins) offre des services qui permettent de réduire les coûts de la recherche des médicaments en identifiant précocement les médicaments les plus prometteurs tout en éliminant les composés susceptibles d'échouer en développement.

keywords:N/A

N/A

Total Funding

169

Number of Employees

$34M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eurofins-Cerep News

2022-04-13 - An efficient and effective PIM3 kinase-focused screening ...

He joined Cerep and Eurofins Discovery over 20 years ago. He is handling in vitro pharmacology studies for client drug discovery programmes (HTS, hit-to-lead,...